{
    "2020-04-02": [
        [
            {
                "time": "",
                "original_text": "沃森生物收年报问询函，说明存货跌价准备计提是否充分 问询",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "年报问询函",
                        "存货跌价准备",
                        "计提"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "国产13价肺炎疫苗上市，或将撬动辉瑞“霸主”地位",
                "features": {
                    "keywords": [
                        "国产13价肺炎疫苗",
                        "上市",
                        "辉瑞",
                        "霸主地位"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}